CVD Risk Estimator Plus is a clinical decision support tool developed by the American College of Cardiology to assist clinicians in assessing cardiovascular disease risk. The app integrates the 2013 ASCVD Pooled Cohort Equations with the 2023 PREVENT™ Equations to provide comprehensive risk modeling. It is notable for incorporating kidney and metabolic health metrics into traditional cardiovascular risk assessments.
Overview · Full Intel report in progress
The App DNA
What makes this app unique?
For Healthcare professionals and clinicians requiring cardiovascular risk assessment tools.
What does it look like?
Key features
Calculates 10-year and lifetime risk of atherosclerotic cardiovascular disease based on traditional factors like blood pressure, cholesterol, and smoking status.
Estimates 10-year and 30-year risk for total CVD, ASCVD, and heart failure by incorporating BMI and eGFR.
Integrates cardiovascular, kidney, and metabolic health measures to provide a more personalized risk assessment.
How much does it cost?
Velocity
Intense developmentShow more...
5 versions in history. Development pace: intense.
Who built it?
American College of Cardiology
13+ apps tracked · Medical
ACC.26
ACC Guideline Clinical App
AnticoagEvaluator
Lipid Manager
TreatHF
ACC Learn
Statin Intolerance
ManageAnticoag
DAPT Risk Calculator
ACC.25
ACC.24
ACC.23/WCCUser Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for CVD Risk Estimator Plus
How's the Medical market?
The rivals identified
The Analyst's Read
Key takeaways for CVD Risk Estimator Plus
Where is it heading?
Bottom line
While the app offers advanced clinical risk equations, recent user feedback highlights significant technical stability issues and functional limitations regarding calculation accuracy.
Report last updated